Article
Potential tumor-specific antigens and immune landscapes identification for mRNA vaccine in thyroid cancer
30 Sept 2024
Abstract excerpt
Background: Tumor mRNA vaccines have been identified as a promising technology for cancer therapy in multiple cancer types, while their efficacy in thyroid cancer (THCA) is unclear. Immunotyping is strongly associated with the immune microenvironment and immune status in cancer, thus it is important in vaccination and therapeutic response. This study is to identify potential valuable antigens and novel immune...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
